ants or Aspirin Study): a randomised trial. Lancet
2000;355:346-51.
143. Arnott C, Huang Y, Neuen BL, Di Tanna GL, Cannon CP, Oh R, et al.
The effect of canagliï¬‚ozin on amputation risk in the CANVAS program and the CREDENCE trial. Diabetes Obes Metab 2020;22:
17